Pacer Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $88.2M | Sell |
732,981
-3,618,416
| -83% | -$418M | 0.25% | 94 |
|
|
2025
Q4 | $458M | Sell |
4,351,397
-885,756
| -17% | -$83.1M | 1.17% | 6 |
|
|
2025
Q3 | $440M | Sell |
5,237,153
-804,609
| -13% | -$66.3M | 1.11% | 12 |
|
|
2025
Q2 | $478M | Buy |
6,041,762
+754,961
| +14% | +$60M | 1.19% | 11 |
|
|
2025
Q1 | $475M | Buy |
5,286,801
+5,060,959
| +2,241% | +$473M | 1.11% | 24 |
|
|
2024
Q4 | $22.5M | Buy |
225,842
+29,377
| +15% | +$3.03M | 0.05% | 311 |
|
|
2024
Q3 | $22.3M | Sell |
196,465
-3,364
| -2% | -$400K | 0.05% | 315 |
|
|
2024
Q2 | $24.7M | Buy |
199,829
+7,641
| +4% | +$984K | 0.06% | 293 |
|
|
2024
Q1 | $25.4M | Sell |
192,188
-49,593
| -21% | -$6.11M | 0.06% | 287 |
|
|
2023
Q4 | $26.4M | Buy |
241,781
+71,517
| +42% | +$7.42M | 0.07% | 258 |
|
|
2023
Q3 | $17.5M | Buy |
170,264
+4,734
| +3% | +$510K | 0.07% | 250 |
|
|
2023
Q2 | $19.1M | Buy |
165,530
+4,936
| +3% | +$560K | 0.08% | 247 |
|
|
2023
Q1 | $17.1M | Buy |
160,594
+41,987
| +35% | +$4.53M | 0.07% | 266 |
|
|
2022
Q4 | $13.2M | Buy |
118,607
+103,244
| +672% | +$10.6M | 0.07% | 231 |
|
|
2022
Q3 | $1.32M | Buy |
15,363
+1,002
| +7% | +$89.4K | 0.01% | 475 |
|
|
2022
Q2 | $1.31M | Sell |
14,361
-185,877
| -93% | -$16.5M | 0.01% | 496 |
|
|
2022
Q1 | $16.4M | Buy |
200,238
+27,250
| +16% | +$2.15M | 0.13% | 140 |
|
|
2021
Q4 | $13.3M | Sell |
172,988
-7,604
| -4% | -$606K | 0.14% | 140 |
|
|
2021
Q3 | $13.6M | Buy |
180,592
+21,658
| +14% | +$1.65M | 0.17% | 81 |
|
|
2021
Q2 | $12.4M | Buy |
158,934
+9,487
| +6% | +$706K | 0.18% | 86 |
|
|
2021
Q1 | $11M | Sell |
149,447
-10,092
| -6% | -$744K | 0.19% | 72 |
|
|
2020
Q4 | $12.5M | Sell |
159,539
-38,160
| -19% | -$2.92M | 0.23% | 63 |
|
|
2020
Q3 | $15.6M | Sell |
197,699
-32,209
| -14% | -$2.52M | 0.33% | 48 |
|
|
2020
Q2 | $17M | Buy |
229,908
+228,967
| +24,332% | +$17.2M | 0.34% | 51 |
|
|
2020
Q1 | $75K | Buy |
941
+147
| +19% | +$11.6K | ﹤0.01% | 515 |
|
|
2019
Q4 | $69K | Sell |
794
-289,291
| -100% | -$23.8M | ﹤0.01% | 1167 |
|
|
2019
Q3 | $23.3M | Buy |
290,085
+28,916
| +11% | +$2.32M | 0.52% | 29 |
|
|
2019
Q2 | $20.9M | Buy |
261,169
+17,146
| +7% | +$1.31M | 0.51% | 33 |
|
|
2019
Q1 | $19.4M | Buy |
244,023
+243,212
| +29,989% | +$18.2M | 0.54% | 30 |
|
|
2018
Q4 | $59K | Sell |
811
-149,212
| -99% | -$10.5M | ﹤0.01% | 280 |
|
|
2018
Q3 | $10.2M | Buy |
150,023
+18,029
| +14% | +$1.15M | 0.38% | 41 |
|
|
2018
Q2 | $7.64M | Buy |
131,994
+23,038
| +21% | +$1.3M | 0.35% | 42 |
|
|
2018
Q1 | $5.66M | Buy |
108,956
+12,204
| +13% | +$659K | 0.31% | 49 |
|
|
2017
Q4 | $5.2M | Sell |
96,752
-7,813
| -7% | -$433K | 0.36% | 38 |
|
|
2017
Q3 | $6.39M | Buy |
104,565
+9,453
| +10% | +$573K | 0.57% | 19 |
|
|
2017
Q2 | $5.82M | Buy |
95,112
+15,286
| +19% | +$930K | 0.58% | 18 |
|
|
2017
Q1 | $4.84M | Buy |
79,826
+8,273
| +12% | +$502K | 0.59% | 18 |
|
|
2016
Q4 | $4.02M | Buy |
71,553
+1,003
| +1% | +$58.7K | 0.57% | 22 |
|
|
2016
Q3 | $4.2M | Buy |
70,550
+6,645
| +10% | +$389K | 0.64% | 20 |
|
|
2016
Q2 | $3.51M | Buy |
63,905
+9,382
| +17% | +$499K | 0.55% | 23 |
|
|
2016
Q1 | $2.75M | Buy |
54,523
+5,551
| +11% | +$272K | 0.62% | 29 |
|
|
2015
Q4 | $2.47M | Buy |
+48,972
| New | +$2.47M | 0.58% | 35 |
|
|
2013
Q4 | $953K | Buy |
+17,591
| New | +$804K | 0.23% | 124 |
|
Other funds holding MRK
VCM
VPM
Pacer Advisors's MRK Position: Q1 2026 in Review
Pacer Advisors reduced its Merck (MRK) stake by 83% in Q1 2026, selling an estimated $418M and leaving 732,981 shares worth $88.2M. The position accounts for 0.25% of the portfolio, ranked #94.
Pacer Advisors first reported a position in MRK in Q4 2013 and has held it in 43 quarters since. The position peaked at $478M in Q2 2025. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Pacer Advisors held 732,981 shares of Merck worth $88.2M as of Q1 2026.
- Pacer Advisors sold 3,618,416 Merck shares in Q1 2026, an estimated $418M.
- Merck made up 0.25% of Pacer Advisors's portfolio in Q1 2026, its #94 holding.
- Pacer Advisors first reported a position in Merck in Q4 2013 and has held it in 43 quarters since.
- Pacer Advisors's Merck position peaked at $478M in Q2 2025.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.